A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy

Chen Xu,1,2,* Rijin Song,1,* Pei Lu,1,* Jianchun Chen,2 Yongqiang Zhou,2 Gang Shen,2 Minjun Jiang,2 Wei Zhang1 1Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, People’s Republic of China; 2Department of Urology, Affiliated Wujiang Hospita...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xu C, Song R, Lu P, Chen J, Zhou Y, Shen G, Jiang M, Zhang W
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/ce3a63e44f9f4fe0bc4bd8a83827312d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ce3a63e44f9f4fe0bc4bd8a83827312d
record_format dspace
spelling oai:doaj.org-article:ce3a63e44f9f4fe0bc4bd8a83827312d2021-12-02T06:46:11ZA pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy1178-2013https://doaj.org/article/ce3a63e44f9f4fe0bc4bd8a83827312d2020-01-01T00:00:00Zhttps://www.dovepress.com/a-ph-responsive-charge-reversal-drug-delivery-system-with-tumor-specif-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Chen Xu,1,2,* Rijin Song,1,* Pei Lu,1,* Jianchun Chen,2 Yongqiang Zhou,2 Gang Shen,2 Minjun Jiang,2 Wei Zhang1 1Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, People’s Republic of China; 2Department of Urology, Affiliated Wujiang Hospital of Nantong Univerisity, Suzhou 215200, People’s Republic of China*These authors contributed equally to this workCorrespondence: Wei Zhang Email weizhangsir@126.comMinjun Jiang Email 463161688@qq.comIntroduction: Poor cell uptake and incomplete intracellular drug release are the two major challenges for polymeric prodrug-based drug delivery systems (PPDDSs) in cancer treatment.Methods: Herein, a PPDDS with pH-induced surface charge-reversal and reactive oxygen species (ROS) amplification for ROS-triggered self-accelerating drug release was developed, which was formed by encapsulating a ROS generation agent (vitamin K3 (VK3)) in pH/ROS dual-sensitive polymetric prodrug (PEG-b-P(LL-g-TK-PTX)-(LL-g-DMA)) based micelle nanoparticles (denoted as PVD-NPs).Results: The surface charge of the PVD-NPs can change from negative to positive for enhanced cell uptake in response to tumor extracellular acidity pH. After internalization by cancer cells, PVD-NPs demonstrate dual drug release in response to intracellular ROS-rich conditions. In addition, the released VK3 can produce ROS under the catalysis by NAD(P)H:quinone oxidoreductase-1, which facilitates tumor-specific ROS amplification and drug release selectively in cancer cells to enhance chemotherapy.Conclusion: Both in vitro and in vivo experiments demonstrated that the PVD-NPs showed significant antitumor activity in human prostate cancer.Keywords: charge-reversal, dual-responsive, ROS generation, cancer specific chemotherapyXu CSong RLu PChen JZhou YShen GJiang MZhang WDove Medical Pressarticlecharge-reversaldual-responsiveros generationcancer specific chemotherapyMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 65-80 (2020)
institution DOAJ
collection DOAJ
language EN
topic charge-reversal
dual-responsive
ros generation
cancer specific chemotherapy
Medicine (General)
R5-920
spellingShingle charge-reversal
dual-responsive
ros generation
cancer specific chemotherapy
Medicine (General)
R5-920
Xu C
Song R
Lu P
Chen J
Zhou Y
Shen G
Jiang M
Zhang W
A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy
description Chen Xu,1,2,* Rijin Song,1,* Pei Lu,1,* Jianchun Chen,2 Yongqiang Zhou,2 Gang Shen,2 Minjun Jiang,2 Wei Zhang1 1Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, People’s Republic of China; 2Department of Urology, Affiliated Wujiang Hospital of Nantong Univerisity, Suzhou 215200, People’s Republic of China*These authors contributed equally to this workCorrespondence: Wei Zhang Email weizhangsir@126.comMinjun Jiang Email 463161688@qq.comIntroduction: Poor cell uptake and incomplete intracellular drug release are the two major challenges for polymeric prodrug-based drug delivery systems (PPDDSs) in cancer treatment.Methods: Herein, a PPDDS with pH-induced surface charge-reversal and reactive oxygen species (ROS) amplification for ROS-triggered self-accelerating drug release was developed, which was formed by encapsulating a ROS generation agent (vitamin K3 (VK3)) in pH/ROS dual-sensitive polymetric prodrug (PEG-b-P(LL-g-TK-PTX)-(LL-g-DMA)) based micelle nanoparticles (denoted as PVD-NPs).Results: The surface charge of the PVD-NPs can change from negative to positive for enhanced cell uptake in response to tumor extracellular acidity pH. After internalization by cancer cells, PVD-NPs demonstrate dual drug release in response to intracellular ROS-rich conditions. In addition, the released VK3 can produce ROS under the catalysis by NAD(P)H:quinone oxidoreductase-1, which facilitates tumor-specific ROS amplification and drug release selectively in cancer cells to enhance chemotherapy.Conclusion: Both in vitro and in vivo experiments demonstrated that the PVD-NPs showed significant antitumor activity in human prostate cancer.Keywords: charge-reversal, dual-responsive, ROS generation, cancer specific chemotherapy
format article
author Xu C
Song R
Lu P
Chen J
Zhou Y
Shen G
Jiang M
Zhang W
author_facet Xu C
Song R
Lu P
Chen J
Zhou Y
Shen G
Jiang M
Zhang W
author_sort Xu C
title A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy
title_short A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy
title_full A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy
title_fullStr A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy
title_full_unstemmed A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy
title_sort ph-responsive charge-reversal drug delivery system with tumor-specific drug release and ros generation for cancer therapy
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/ce3a63e44f9f4fe0bc4bd8a83827312d
work_keys_str_mv AT xuc aphresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT songr aphresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT lup aphresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT chenj aphresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT zhouy aphresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT sheng aphresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT jiangm aphresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT zhangw aphresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT xuc phresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT songr phresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT lup phresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT chenj phresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT zhouy phresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT sheng phresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT jiangm phresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
AT zhangw phresponsivechargereversaldrugdeliverysystemwithtumorspecificdrugreleaseandrosgenerationforcancertherapy
_version_ 1718399778752036864